|
PAWR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.98670000001378E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.25540000617264E-09 |
| Normal-vs-Stage2 |
1.338300E-03 |
| Normal-vs-Stage3 |
7.180500E-03 |
| Normal-vs-Stage4 |
3.582000E-01 |
| Stage1-vs-Stage2 |
3.715600E-01 |
| Stage1-vs-Stage3 |
1.755160E-01 |
| Stage1-vs-Stage4 |
2.266400E-01 |
| Stage2-vs-Stage3 |
6.655800E-01 |
| Stage2-vs-Stage4 |
3.578800E-01 |
| Stage3-vs-Stage4 |
5.443000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.61560000003325E-06 |
| Normal-vs-AfricanAmerican |
1.593790E-04 |
| Normal-vs-Asian |
1.677840E-02 |
| Caucasian-vs-AfricanAmerican |
3.595400E-01 |
| Caucasian-vs-Asian |
9.146000E-01 |
| AfricanAmerican-vs-Asian |
8.178000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.86080000192024E-08 |
| Normal-vs-Female |
3.124700E-03 |
| Male-vs-Female |
4.912400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.06090000001813E-06 |
| Normal-vs-Extreme_Weight |
4.65229998969363E-09 |
| Normal-vs-Obese |
1.335380E-03 |
| Normal-vs-Extreme_Obese |
4.33680000000436E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.416800E-01 |
| Normal_Weight-vs-Obese |
2.539800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.523600E-01 |
| Extreme_Weight-vs-Obese |
5.701700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.927800E-01 |
| Obese-vs-Extreme_Obese |
4.393800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.320000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.73465999999678E-05 |
| Normal-vs-Age(61-80Yrs) |
1.18690000050492E-08 |
| Normal-vs-Age(81-100Yrs) |
7.31300000000878E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.013900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.354200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.543200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.002000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.806400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.686230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.14059999947835E-07 |
| Normal-VS-Type2 PRCC |
6.98380242525332E-11 |
| Normal-VS-KIRP CIMP |
2.110400E-01 |
| Normal-VS-Unclassified PRCC |
4.420300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.039900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.362100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.676600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.328080E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.925700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.066200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85670000485416E-08 |
| Normal-vs-N1 |
9.873400E-01 |
| Normal-vs-N2 |
6.176100E-02 |
| N0-vs-N1 |
9.402000E-03 |
| N0-vs-N2 |
5.390000E-01 |
| N1-vs-N2 |
3.793400E-01 |
|
|
